IN THE UNITED STATES DISTRICT COURT

KELLYN CLAY,
  Plaintiff,

v.

UNITED STATES OF AMERICA,
by and through its agencies including but not limited to
the Central Intelligence Agency (CIA), Department of Defense (DoD),
and Food and Drug Administration (FDA),

and

JOHN DOE DEFENSE CONTRACTORS,
whose names and identities are presently unknown,
  Defendants.

⸻

[PROPOSED] ORDER GRANTING INJUNCTIVE RELIEF

⸻

Upon consideration of Plaintiff’s motion and supporting memorandum regarding the inadmissibility of data extracted through nonconsensual neurotechnology arrays, and for good cause shown, IT IS HEREBY ORDERED:
	1.	Admissibility of Evidence.
 Any and all data derived from neurotechnology arrays or comparable invasive surveillance devices installed or operated without an individual’s informed consent shall be deemed inadmissible in any judicial, administrative, or quasi-judicial proceeding.
	2.	Prohibition on Reliance by Contractors.
 Private defense contractors, subcontractors, or affiliated entities are hereby enjoined from using, referencing, or relying upon such tainted data as a justification for continued or escalated surveillance, anomaly classification, or behavioral manipulation.
	3.	Prohibition on Reliance by Government Agencies.
 Federal agencies, including but not limited to the CIA, DoD, and FDA, are likewise enjoined from accepting or acting upon such data, whether directly or through third-party contractors.
	4.	Expungement of Records.
 Defendants shall identify and segregate all records derived from nonconsensual neurotechnology arrays and place such data under protective seal, pending further order of this Court.
	5.	Scope and Enforcement.
 This Order applies nationwide to all programs, pilot projects, and derivative markets employing nonconsensual neurotechnology data. Failure to comply shall subject Defendants to contempt sanctions and further injunctive remedies.

⸻

SO ORDERED.

Dated: 8/29/2025

⸻

United States District Judge
